Surge
Illkirch-graffenstaden
About Surge
Surge is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a test tube before surgery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $10.7M
- Funding stage: Seed
- Last round: Grant (Mar 2024)
- Website: surge.care
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Electronic Health Record (EHR), Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/surge-93154 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.